Loading insider details...
Beta
Latest Form 4 (Jun 13, 2024): Grant/Award of 24,200 ITOS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 13, 2024 | iTeos Therapeutics, Inc. (ITOS) | Grant/Award | 24,200 | n/a |
| Dec 8, 2021 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 26,667 | n/a |
| Oct 19, 2021 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,800 | n/a |
| Mar 12, 2021 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 4,583 | n/a |
| Mar 9, 2021 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 3,333 | n/a |
| Dec 22, 2020 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 23,551 | $398.0K |
| Oct 6, 2020 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 16,666 | n/a |
| Jun 24, 2020 | CRISPR Therapeutics AG (CRSP) | Sale | 229 | $16.1K |
| May 27, 2020 | CRISPR Therapeutics AG (CRSP) | Sale | 600 | $42.0K |
| Mar 12, 2020 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 55,000 | n/a |